Since 2016, Mr. Packer has held the role of Primary Executive Officer of Asahi Kasei Group, leading the corporation’s global Health Care Business Unit, made up of Asahi Kasei Pharma, Veloxis Pharmaceuticals, ZOLL Medical, Asahi Medical Bioprocess, and Asahi Kasei Medical Blood Purification, with combined global revenues approximating $4 billion. Mr. Packer is a senior member of the Asahi Kasei executive management team and the only non-Japanese person to hold such a role.
Mr. Packer also acts as the non-executive Chairman of ZOLL Medical, a $2 billion medical technology company focused on critical care medicine. In 2012, ZOLL became part of the Asahi Kasei Group, a $20 billion Japanese conglomerate. Mr. Packer served as CEO of ZOLL Medical Inc., a NASDAQ listed company, from November 1999 until 2016. Mr. Packer joined ZOLL in 1992, becoming President in 1995.
Mr. Packer received B.S. and M. Eng. Degrees from the Rensselaer Polytechnic Institute and an MBA degree from the Harvard Graduate School of Business Administration.
Mr. Packer serves on the BOD of several public and private companies, as well as on the board of the Medical Device Manufactures Association (MDMA). Mr. Packer is past Chairperson, and Director Emeritus of MassMEDIC. He was an original member of the Steering Committee for the Massachusetts Life Sciences Collaborative.
